Interventional cardiology and diabetes mellitus: age of effective coronary heart disease treatment
https://doi.org/10.14341/2072-0351-6251
Abstract
Introduction into clinical practice of coronary angioplasty has provided new possibilities for treatment of coronary heart disease (CHD) in patientswith diabetes mellitus. The indications for endovascular interventions and principles of coronary stenting in such patients are described in this article.
About the Authors
Victor Yur'evich Kalashnikov
Endocrinology Research Centre, Moscow
Irina Ziyatovna Bondarenko
Endocrinology Research Centre, Moscow
Alexander Borisovich Kuznetsov
Endocrinology Research Centre, Moscow
Diana Dzhemalovna Beshlieva
Endocrinology Research Centre, Moscow
Sergey Anatol'evich Terekhin
Endocrinology Research Centre, Moscow
Konstantin Vladimirovich Melkozerov
Endocrinology Research Centre, Moscow
References
1. Cook S., Windecker S. Revascularisation of coronary disease in patients with diabetes mellitu s // Swiss Med WKLY. - 2009. - №139 (45-46). - Р. 654-664. www.smw.ch.
2. Henderson R.A., Pocock S.J., Sharp S.J. Long term results of RITA-1 trial: clinical and cost comparisons of coronary angioplasty and coronary artery bypass grafting. Randomized intervention treatment of angina // Lancet. - 1998. - №352. - Р. 1419-1425.
3. Kurbaan A.S., Bowker T.I., Ilsley C.D. Differens in the mortality of the CABRI diabetic and nondiabetic populations and its relation to coronary artery disease and the revascularization mode // Am. J. Cardiol. - 2001. - №81. - Р. 947-950.
4. Zhao H.Q, Brown B.G., Stewat D.K. Effectiveness of revascularization in the Emory Angioplasty versus surgery trial. A randomized comparison of coronary angioplasty with bypass surgery // Circulation. - 1996. - №93. - Р. 1954-19620.
5. Niles N.V., McGrath P.D., Malenka D. Northern New England Сardiovascular Disease Study Group. Survial of patients with diabetes and multivessel coronary artery disease after surdica l or percutaneous revascularization: results of a large regional prospective study // J. Am. Co ll. Cardiol. - 2001. - №37. - Р. 1008-1015.
6. Wijns W., Kolh Ph., Danchin N., Di Mario C., Falk V., Folliguet T., Garg S. et all., P. EACTS Clinical Guidelines Committee: Kolh Ph, Alfieri O, Dunning J, Elia S, Kappetein P, Lockowandt U , Sarris G, Vouhe P. Guidelines on myocardial revascularization. The Task Force on Myocardia l Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) // Eur Heart J. 2010 Oct;31(20):2501-55.
7. BARI 2D Study Group. A randomized trial of therapies for type 2 diabetes and coronary artery disease // N. Engl. J. Med. - 2009. - №360. - Р. 2503-2515.
8. Patti G., Nusca A., Di Sciascio G. Meta-analysis comparison (nine trials) of outcomes with drug-eluting stents versus bare metal stents in patients with diabetes mellitus // Am. J. Cardio l. - 2008. - №102(10). - Р. 1328-1334.
9. Mandelzweig L., Battler A., Boyko V. The second Euro Heart Survey on acute coronary syndromes: characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin in 2004 // European Heart Journal. - 2006. - №27. - Р. 2285-2293.
10. Damman P., Hirsch A., Windhausen F. 5-year clinical outcomes in the ICTUS (Invasive versu s Conservative Treatment in Unstable coronary Syndromes) trial: a randomized comparison o f an early invasive versus selective invasive management in patients with non-ST-segment elevation acute coronary syndrome // J. Am. Coll. Cardiol. - 2010. - №55. - Р. 858-864.
11. Invasive compared with non-invasive treatment in unstable coronary artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease Investigators // Lancet. - 1999. - №354. - Р. 708-715.
12. Вhatt D.L., Roe M.T., Peterson E.D. Utilization of Early Invasive Management Strategies o r High-Risk Patients With Non-ST-Segment Elevation Acute Coronary Syndromes. Results From the CRUSADE Quality Improvement Initiative // JAMA. - 2004. - №292. - Р. 2096- 2104.
13. Silber S., Albertsson P., Avileґs F.F., Camici P.G., Colombo A., Hamm C., Jшrgensen E, Marco J, Nordrehaug J-E, Ruzyllo W, Urban P, Stone GW, Wijns W. ESC Committee for Practice Guidelines (CPG): Priori S.G., Garcia M.A.A., Blanc J-J., Budaj A., Cowie M., Dean V., Deckers J., Burgos E.F., Lekakis J., Lindahl B., Mazzotta G., McGregor K., Morais J., Oto A., Smise th O. Guidelines for Percutaneous Coronary Interventions The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology // European Heart Journal. - 2005. - 26. - P.804-847.
14. Norhammar A., Malmberg K., Diderholm E. Diabetes Mellitus: The Major Risk Factor in Unstable Coronary Artery Disease Even After Consideration of the Extent of Coronary Artery Disease and Benefits of Revascularization // J. Am. Coll. Cardiol. - 2004. - №43. - Р. 585-91.
15. Norhammar A., Lagerqvist B., Saleh N. Long-term mortality after PCI in patients with diabete s mellitus: results from the Swedish Coronary Angiography and Angioplasty Registry // EuroIntervention. - 2010 - Apr.№5(8). - Р. 891-897.
16. Yan R.T., Yan A.T., Tan M. Canadian Acute Coronary Syndrome Registry Investigators. Underuse of evidence-based treatment partly explains the worse clinical outcome in diabetic patien ts with acute coronary syndromes // Am. Heart J. - 2006. - №152(4). - Р. 676-683 .
17. Brogan G.X., Peterson E.D., Mulgund et al. Treatment Disparities in the Care of Patients Wit h and Without Diabetes Presenting With Non-ST-Segment Elevation Acute Coronary Syndromes // Diabetes Care. - 2006. - №29. - Р. 9-14.
18. Bauer A., Malik M., Schmidt G. Heart Rate Turbulence: Standards of Measurement, Physiological Interpretation, and Clinical Journal of the American College of Cardiology. - 2008. - Vo l. 52. - №17. - Р. 1353-1365.
19. Bassand J.P., Hamm C.W., Ardissino D., Boersma E., Budaj A., Fernández-Avilés F., Fox K.A., Hasdai D., Ohman E.M., Wallentin L., Wijns W. Guidelines for the diagnosis and treatment o f non-ST-segment elevation acute coronary syndromes // European Heart Journal. - 2007. - 28. - Р.1598-1660.
20. Lee M.S., Yang T., Dhoot J., Iqbal Z., Liao H. Meta-analysis of studies comparing coronary artery bypass grafting with drug-eluting stenting in patients with diabetes mellitus and multivesse l coronary artery disease // Am. J. Cardiol. - 2010. - №105(11). - Р. 1540-1544.
21. Banning A.P., Westaby S., Morice M.C., Kappetein A.P., Mohr F.W., Berti S., Glauber M ., Kellett M.A., Kramer R.S., Leadley K., Dawkins K.D., Serruys P.W. Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents // J. Am. Coll Cardiol. - 2010. - №55 (11). - Р. 1067-1075.
22. Кapur A., Hall R.J., Malik I.S., Qureshi A.C., Butts J., de Belder M., Baumbach A., Angelini G., d e Belder A., Oldroyd K.G., Flather M., Roughton M., Nihoyannopoulos P., Bagger J.P., Morgan K., Beatt K.J. Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial // J. Am. Coll. Cardiol. - 2010. - №2; 55 (5). - Р. 432-440.
23. Scheen A.J., Warsee F., Legran V.M. G Drag-eluting stents: a meta-analysis in diabetec patien ts // Eur. Heart J. - 2004. - №25. - Р. 2167-2168.
24. Airoldi F., Briguori C., Iakovou I., Stankovic G., Biondi-Zoccai G., Carlino M., Chieffo A., Montorfano M., Cosgrave J., Michev I., Rogacka R., Sangiorgi G.M. Colombo A: Comparison o f sirolimus versus paclitaxel eluting stents for treatment of coronary in-stent restenosis // Am. J. Cardiol. - 2006. - №97. - Р. 1182-1187.
25. Williams D.O., King S.B. 3rd, Smith S.C. Jr. 2007 Focused Update of the ACC/AHA/SCA I 2005 Guideline Update for Percutaneous Coronary Intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New Evidence and Update the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention, Writing on Behalf of the 2005 Writing Committee. Circulation. 2008 Feb 12;117(6): e161
Review
For citations:
Kalashnikov V.Yu., Bondarenko I.Z., Kuznetsov A.B., Beshlieva D., Terekhin S.A., Melkozerov K.V. Interventional cardiology and diabetes mellitus: age of effective coronary heart disease treatment. Diabetes mellitus. 2011;14(1):61-68. (In Russ.) https://doi.org/10.14341/2072-0351-6251
Views:
713
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
